YourVaccx™
YourVaccx™* is a breakthrough therapy for metastatic solid tumor cancers that empowers the immune system to attack metastatic cancer throughout the body.
YourVaccx™
The YourVaccx therapy empowers the patient’s immune system to create a personal in-situ autologous vaccine that attacks cancer throughout the entire body. The following illustration depicts an overview of the steps involved in the therapy:
A segment of a tumor undergoes
controlled cellular lysis,
liberating tumor antigens and
other molecules that serve to
activate the immune system.
A proprietary immunotherapy
drug is locally injected that
provides both a checkpoint
blockade and immune
stimulation.
This combination approach
empowers the immune system to create an in situ autologous
vaccine that drives an abscopal effect that attacks the metastatic cancer throughout the body.
Gary Onik, M.D.
Inventor, Physician & Patient
-
Dr. Onik was diagnosed with a very aggressive metastatic prostate cancer in October 2018.
-Metastasized to bone, pelvis and distant areas
-PSA of 138 - He underwent the YourVaccx ™ therapy, receiving two cycles of treatment in early and late December 2018.
- Dr. Onik achieved a Complete Response and currently remains without evidence of recurrence to date.
Revolutionary Approach to Empowering the Immune System
YourVaccx™* is a breakthrough therapy for metastatic solid tumor cancers that empowers the immune system to attack metastatic cancer throughout the body.
